Table 1.
Baseline characteristics of study participants.
| Case (n = 1170) | Control (n = 1170) | |
|---|---|---|
| Age* | 51.3 (11.1) | 51.4 (11.1) |
| Menopausal Age | 46.7 (6.7) | 47.3 (6.7) |
| Height | 160.3 (4.6) | 159.8 (4.6) |
| Weight | 61.3 (9.0) | 59.9 (8.8) |
| Menopause, % | 50.5 | 51.6 |
| Pathologic type | ||
| Her2+% | 53.7 | 53.6 |
| ER/PR+Her2- % | 33.4 | 33.9 |
| ER/PR-Her2-% | 12.9 | 12.5 |
| Neoadjuvant chemotherapy (positive)% |
21.3 | 4.0 |
| Ultrasound (positive) % | 62.9 | 26.6 |
| Mammogram (positive) % | 22.2 | 11.7 |
| MRI (positive) % | 67.9 | 33.1 |
Values are means (SD) for continuous variables; percentages for categorical variables, and are standardized to the age distribution of the study population.
*Value is not age adjusted.